ADVFN ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Apellis Pharmaceuticals Inc

Apellis Pharmaceuticals Inc (APLS)

17.89
0.47
(2.70%)
17.87
-0.02
(-0.11%)

Apellis Pharmaceuticals Inc Financial Summary

The current APLS market cap is 2.25B. The company's latest EPS is USD -1.5744 and P/E is -11.36.

Quarter End Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 172.33M199.68M196.83M212.53M166.8M
Operating Income -62.09M-29.44M-47.28M-26.16M-83.33M
Net Income -66.42M-37.66M-57.45M-36.35M-92.23M
Year End 31 December 2024 20202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 250.65M66.56M75.42M396.59M781.37M
Operating Income -213.73M-536.28M-594.61M-517.12M-164.98M
Net Income -344.87M-746.35M-652.17M-525.63M-197.88M
Quarter End Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 831.93M904.48M901.87M885.05M807.29M
Total Liabilities 565.25M640.16M664.75M656.51M643.07M
Total Equity 266.68M264.33M237.12M228.54M164.22M
Year End 31 December 2024 20202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 960.57M881.77M760.22M788.73M885.05M
Total Liabilities 756.01M683.1M590.35M594.21M656.51M
Total Equity 204.56M198.66M169.87M194.52M228.54M
Quarter End Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -132.98M-141.32M-107.23M-87.87M-53.41M
Investing -293k-383k-383k-403k-8k
Financing 108.21M150.7M153.24M149.24M274k
Year End 31 December 2024 20202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -160.49M-563.13M-513.75M-594.74M-87.87M
Investing -316.99M247.62M59.89M-674k-403k
Financing 692.18M392.24M365.66M394.5M149.24M
Market Cap 2.25B
Price to Earnings Ratio -11.36
Price to Sales Ratio 2.88
Price to Cash Ratio 5.47
Price to Book Ratio 9.84
Dividend Yield -

Share Statistics

Shares Outstanding 125.68M
Average Volume (1 week) 1.79M
Average Volume (1 Month) 1.86M
52 Week Change -51.15%
52 Week High 42.47
52 Week Low 16.10
Spread (Intraday) 0.06 (0.34%)

Company Info

Company Name Apellis Pharmaceuticals Inc
Address 108 lakeland ave
dover, delaware 19901
Website https://www.apellis.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock